#/6%2 !

24)#,%
02/",%- /2)%.4%$ $)!'./3)3

!BNORMAL 5TERINE "LEEDING

*!.%4 2 !,"%23 -$ 3(!2/. + (5,, -$ AND 2/"%24 - 7%3,%9 -!
3OUTHERN )LLINOIS 5NIVERSITY 3CHOOL OF -EDICINE 3PRINGFIELD )LLINOIS

!BNORMALUTERINEBLEEDINGISACOMMONPRESENTINGSYMPTOMINTHEFAMILYPRACTICESETTING)NWOMEN
OFCHILDBEARINGAGEAMETHODICALHISTORYPHYSICALEXAMINATIONANDLABORATORYEVALUATIONMAYENABLE / ! PATIENT INFOR
THEPHYSICIANTORULEOUTCAUSESSUCHASPREGNANCYANDPREGNANCY RELATEDDISORDERSMEDICATIONSIATRO MATION HANDOUT ON
ABNORMAL UTERINE
GENICCAUSESSYSTEMICCONDITIONSANDOBVIOUSGENITALTRACTPATHOLOGY$YSFUNCTIONALUTERINEBLEEDING
BLEEDING WRITTEN BY
ANOVULATORYOROVULATORY ISDIAGNOSEDBYEXCLUSIONOFTHESECAUSES)NWOMENOFCHILDBEARINGAGEWHO THE AUTHORS OF THIS
AREATHIGHRISKFORENDOMETRIALCANCERTHEINITIALEVALUATIONINCLUDESENDOMETRIALBIOPSYSALINE INFUSION ARTICLE IS PROVIDED
SONOHYSTEROGRAPHYORDIAGNOSTICHYSTEROSCOPYISPERFORMEDIFINITIALSTUDIESAREINCONCLUSIVEORTHEBLEED ON PAGE 
INGCONTINUES7OMENOFCHILDBEARINGAGEWHOAREATLOWRISKFORENDOMETRIALCANCERMAYBEASSESSED
INITIALLYBYTRANSVAGINALULTRASONOGRAPHY0OSTMENOPAUSALWOMENWITHABNORMALUTERINEBLEEDINGSHOULD
BEOFFEREDDILATATIONANDCURETTAGEIFTHEYAREPOORCANDIDATESFORGENERALANESTHESIAORDECLINEDILATATION
ANDCURETTAGETHEYMAYBEOFFEREDTRANSVAGINALULTRASONOGRAPHYORSALINE INFUSIONSONOHYSTEROGRAPHY
WITHDIRECTEDENDOMETRIALBIOPSY-EDICALMANAGEMENTOFANOVULATORYDYSFUNCTIONALUTERINEBLEEDING
MAYINCLUDEORALCONTRACEPTIVEPILLSORCYCLICPROGESTINS-ENORRHAGIAISMANAGEDMOSTEFFECTIVELYWITH
NONSTEROIDALANTI INFLAMMATORYDRUGSORTHELEVONORGESTRELINTRAUTERINECONTRACEPTIVEDEVICE3URGICAL
MANAGEMENTMAYINCLUDEHYSTERECTOMYORLESSINVASIVEUTERUS SPARINGPROCEDURES!M&AM0HYSICIAN
   #OPYRIGHT¥  !MERICAN !CADEMY OF &AMILY 0HYSICIANS

!
BNORMALUTERINEBLEEDINGIS WOMEN WHO HAVE BEEN RECEIVING HORMONE
ACOMMONBUTCOMPLICATED THERAPY FOR  MONTHS OR MORE
CLINICAL PRESENTATION /NE 4HIS ARTICLE PRESENTS A PRACTICAL APPROACH
NATIONAL STUDY FOUND THAT TODETERMININGTHECAUSEOFABNORMALUTERINE
MENSTRUAL DISORDERS WERE BLEEDINGANDBRIEFLYREVIEWSMEDICALANDSUR
THE REASON FOR  PERCENT OF  MILLION GICAL MANAGEMENT
VISITS TO PHYSICIAN OFFICES FOR GYNECOLOGIC
CONDITIONSOVERATWO YEARPERIOD&URTHER %TIOLOGY AND %VALUATION
MOREA REPORTED  PERCENT OF GYNECOLOGIC OF !BNORMAL 5TERINE "LEEDING
SURGERIES INVOLVE ABNORMAL UTERINE BLEED "%&/2% -%.!2#(%
-EMBERS OF VARIOUS FAM ING -ALIGNANCYTRAUMAANDSEXUALABUSEOR
ILY PRACTICE DEPARTMENTS
%XCEPTFORSELF LIMITEDPHYSIOLOGICWITH ASSAULT ARE POTENTIAL CAUSES OF ABNORMAL
DEVELOP ARTICLES FOR h0ROB
LEM /RIENTED $IAGNOSISv DRAWAL BLEEDING THAT OCCURS IN SOME NEW UTERINE BLEEDING BEFORE MENARCHE ! PEL
4HIS IS ONE IN A SERIES FROM BORNS VAGINAL BLEEDING BEFORE MENARCHE VICEXAMINATIONPOSSIBLYUNDERANESTHESIA
THE $EPARTMENT OF &AMILY IS ABNORMAL )N WOMEN OF CHILDBEARING SHOULD BE PERFORMED BECAUSE A REPORTED
AND #OMMUNITY -EDICINE AGE ABNORMAL UTERINE BLEEDING INCLUDES  PERCENT OF CASES INVOLVE FOCAL LESIONS OF
AT 3OUTHERN )LLINOIS 5NIVER
ANYCHANGEINMENSTRUAL PERIODFREQUENCY THE GENITAL TRACT AND  PERCENT OF THESE
SITY 3CHOOL OF -EDICINE
3PRINGFIELD 'UEST EDITOR OR DURATION OR AMOUNT OF FLOW AS WELL AS LESIONS MAY BE MALIGNANT
OF THE SERIES IS *OHN ' BLEEDINGBETWEENCYCLES !MENORRHEAOR
"RADLEY -$ PROFESSOR THE CESSATION OF MENSES FOR SIX MONTHS OR #(),$"%!2).' 9%!23
AND DIRECTOR OF THE $ECATUR MOREINNONMENOPAUSALWOMENISBEYOND 4HE MENSTRUAL CYCLE HAS THREE PHASES
&AMILY 0RACTICE 2ESIDENCY
THE SCOPE OF THIS ARTICLE )N POSTMENO $URING THE FOLLICULAR PHASEFOLLICLE STIMU
0ROGRAM
PAUSAL WOMENABNORMAL UTERINE BLEEDING LATING HORMONE LEVELS INCREASE CAUSING
3EE PAGE  FOR DEFI INCLUDES VAGINAL BLEEDING  MONTHS OR A DOMINANT FOLLICLE TO MATURE AND PRO
NITIONS OF STRENGTH OF MORE AFTER THE CESSATION OF MENSES OR DUCE ESTROGEN IN THE GRANULOSA CELLS 7ITH
RECOMMENDATION LABELS UNPREDICTABLEBLEEDINGINPOSTMENOPAUSAL ESTROGEN ELEVATION MENSTRUAL FLOW CEASES

$OWNLOADED FROM THE !MERICAN &AMILY 0HYSICIAN 7EB SITE AT WWWAAFPORGAFP #OPYRIGHT¥  !MERICAN !CADEMY OF &AMILY 0HYSICIANS &OR THE PRI
VATE NONCOMMERCIAL USE OF ONE INDIVIDUAL USER OF THE 7EB SITE !LL OTHER RIGHTS RESERVED #ONTACT COPYRIGHTS AAFPORG FOR COPYRIGHT QUESTIONS ANDOR
 4!",% 
$IFFERENTIAL $IAGNOSIS OF !BNORMAL 5TERINE "LEEDING

0REGNANCY AND PREGNANCY

RELATED CONDITIONS 3YSTEMIC CONDITIONS 'ENITAL TRACT PATHOLOGY
!BRUPTIO PLACENTAE !DRENAL HYPERPLASIA AND )NFECTIONS CERVICITIS ENDOMETRITIS
%CTOPIC PREGNANCY #USHINGS DISEASE MYOMETRITIS SALPINGITIS
-ISCARRIAGE "LOOD DYSCRASIAS INCLUDING .EOPLASTIC ENTITIES
0LACENTA PREVIA LEUKEMIA AND "ENIGN ANATOMIC ABNORMALITIES
4ROPHOBLASTIC DISEASE THROMBOCYTOPENIA ADENOMYOSIS LEIOMYOMATA
-EDICATIONS AND IATROGENIC CAUSES #OAGULOPATHIES POLYPS OF THE CERVIX OR ENDOME
(EPATIC DISEASE TRIUM
!NTICOAGULANTS
(YPOTHALAMIC SUPPRESSION 0REMALIGNANT LESIONS CERVICAL
!NTIPSYCHOTICS
FROM STRESS WEIGHT LOSS DYSPLASIA ENDOMETRIAL
#ORTICOSTEROIDS
EXCESSIVE EXERCISE HYPERPLASIA
(ERBAL AND OTHER SUPPLEMENTS
0ITUITARY ADENOMA OR -ALIGNANT LESIONS CERVICAL
GINSENG GINKGO SOY
HYPERPROLACTINEMIA SQUAMOUS CELL CARCINOMA
(ORMONE REPLACEMENT ENDOMETRIAL ADENOCARCINOMA
0OLYCYSTIC OVARY SYNDROME
)NTRAUTERINE DEVICES ESTROGEN PRODUCING OVARIAN
2ENAL DISEASE
/RAL CONTRACEPTIVE PILLS TUMORS TESTOSTERONE PRODUCING
4HYROID DISEASE
INCLUDING PROGESTIN ONLY PILLS OVARIAN TUMORS LEIOMYOSARCOMA
3ELECTIVE SEROTONIN REUPTAKE 4RAUMA FOREIGN BODY ABRASIONS
INHIBITORS LACERATIONS SEXUAL ABUSE OR ASSAULT
4AMOXIFEN .OLVADEX 
$YSFUNCTIONAL UTERINE BLEEDING
4HYROID HORMONE REPLACEMENT DIAGNOSIS OF EXCLUSION

)NFORMATION FROM REFERENCES  AND 

THEENDOMETRIUMPROLIFERATESANDPOSITIVEFEED ACTIVITY ! BIMANUAL PELVIC EXAMINATION SEEK

BACK IS EXERTED ON LUTEINIZING HORMONE ,(  INGUTERINEENLARGEMENT ABETA SUBUNITHUMAN
RESULTING IN THE OVULATORY PHASE $URING THE CHORIONICGONADOTROPINTESTANDPELVICULTRASO
LUTEAL PHASE PROGESTERONE ELEVATION HALTS PRO NOGRAPHY ARE USEFUL IN ESTABLISHING OR RULING OUT
LIFERATIONOF THEENDOMETRIUMANDPROMOTESITS PREGNANCY AND PREGNANCY RELATED DISORDERS
DIFFERENTIATIONPROGESTERONEPRODUCTIONBYTHE .EXT IATROGENIC CAUSES OF ABNORMAL UTER
CORPUSLUTEUMDIMINISHESCAUSINGENDOMETRIAL INE BLEEDING SHOULD BE EXPLORED "LEEDING MAY
SHEDDINGORMENSTRUATION!MENSTRUALCYCLEOF BE INDUCED BY MEDICATIONS INCLUDING ANTICO
FEWER THAN  DAYS OR MORE THAN  DAYS OR A AGULANTS SELECTIVE SEROTONIN REUPTAKE INHIBI
MENSTRUAL FLOW OF FEWER THAN TWO DAYS OR MORE TORS ANTIPSYCHOTICS CORTICOSTEROIDS HORMONAL
THANSEVENDAYSISCONSIDEREDABNORMALPP  MEDICATIONSANDTAMOXIFEN.OLVADEX (ERBAL
0REGNANCYISTHEFIRSTCONSIDERATIONINWOMEN SUBSTANCES INCLUDING GINSENG GINKGO AND SOY
OF CHILDBEARING AGE WHO PRESENT WITH ABNORMAL SUPPLEMENTSMAYCAUSEMENSTRUALIRREGULARITIES
UTERINE BLEEDING 4ABLE   0OTENTIAL CAUSES OF BY ALTERING ESTROGEN LEVELS OR CLOTTING PARAM
PREGNANCY RELATEDBLEEDINGINCLUDESPONTANEOUS ETERS
PREGNANCYLOSSMISCARRIAGE ECTOPICPREGNANCY /NCE PREGNANCY AND IATROGENIC CAUSES HAVE
PLACENTAPREVIAABRUPTIOPLACENTAEANDTROPHO BEEN EXCLUDEDPATIENTS SHOULD BE EVALUATED FOR
BLASTIC DISEASE 0ATIENTS SHOULD BE QUESTIONED SYSTEMIC DISORDERS PARTICULARLY THYROID HEMA
ABOUT CYCLE PATTERNS CONTRACEPTION AND SEXUAL TOLOGICHEPATICADRENALPITUITARYANDHYPOTHA

 !-%2)#!. &!-),9 0(93)#)!. WWWAAFPORGAFP 6/,5-%  .5-"%2   !02),  

4!",% 
%VALUATION OF !BNORMAL 5TERINE "LEEDING

$IAGNOSTIC STEP 0ERTINENT SIGNS SYMPTOMS AND TESTS #ONDITIONS

(ISTORY 0ELVIC PAIN -ISCARRIAGE ECTOPIC PREGNANCY 0)$ TRAUMA

SEXUAL ABUSE OR ASSAULT
.AUSEA WEIGHT GAIN URINARY FREQUENCY FATIGUE 0REGNANCY
7EIGHT GAIN COLD INTOLERANCE CONSTIPATION FATIGUE (YPOTHYROIDISM
7EIGHT LOSS SWEATING PALPITATIONS (YPERTHYROIDISM
%ASY BRUISING TENDENCY TO BLEED #OAGULOPATHY
*AUNDICE HISTORY OF HEPATITIS ,IVER DISEASE
(IRSUTISM ACNE ACANTHOSIS NIGRICANS OBESITY 0OLYCYSTIC OVARY SYNDROME
0OSTCOITAL BLEEDING #ERVICAL DYSPLASIA ENDOCERVICAL POLYPS
'ALACTORRHEA HEADACHE VISUAL FIELD DISTURBANCE 0ITUITARY ADENOMA
7EIGHT LOSS EXCESSIVE EXERCISE STRESS (YPOTHALAMIC SUPPRESSION
0HYSICAL EXAMINATION 4HYROMEGALY WEIGHT GAIN EDEMA (YPOTHYROIDISM
4HYROID TENDERNESS TACHYCARDIA WEIGHT LOSS VELVETY SKIN (YPERTHYROIDISM
"RUISING JAUNDICE HEPATOMEGALY ,IVER DISEASE
%NLARGED UTERUS 0REGNANCY LEIOMYOMA UTERINE CANCER
&IRM FIXED UTERUS 5TERINE CANCER
!DNEXAL MASS /VARIAN TUMOR ECTOPIC PREGNANCY CYST
5TERINE TENDERNESS CERVICAL MOTION TENDERNESS 0)$ ENDOMETRITIS
,ABORATORY TESTS "ETA SUBUNIT HUMAN CHORIONIC GONADOTROPIN 0REGNANCY
#OMPLETE BLOOD COUNT WITH PLATELET COUNT AND #OAGULOPATHY
COAGULATION STUDIES
,IVER FUNCTION TESTS PROTHROMBIN TIME ,IVER DISEASE
4HYROID STIMULATING HORMONE (YPOTHYROIDISM HYPERTHYROIDISM
0ROLACTIN 0ITUITARY ADENOMA
"LOOD GLUCOSE $IABETES MELLITUS
$(%! 3 FREE TESTOSTERONE G HYDROXYPROGESTERONE /VARIAN OR ADRENAL TUMOR
IF HYPERANDROGENIC
0APANICOLAOU SMEAR #ERVICAL DYSPLASIA
#ERVICAL TESTING FOR INFECTION #ERVICITIS 0)$
)MAGING AND TISSUE %NDOMETRIAL BIOPSY OR DILATATION AND CURETTAGE (YPERPLASIA ATYPIA OR ADENOCARCINOMA
SAMPLING 4RANSVAGINAL ULTRASONOGRAPHY 0REGNANCY OVARIAN OR UTERINE TUMORS
3ALINE INFUSION SONOHYSTEROGRAPHY )NTRACAVITARY LESIONS POLYPS SUBMUCOUS FIBROIDS
(YSTEROSCOPY )NTRACAVITARY LESIONS POLYPS SUBMUCOUS FIBROIDS

0)$  PELVIC INFLAMMATORY DISEASE $(%! 3  DEHYDROEPIANDROSTERONE SULFATE

LAMIC CONDITIONS 4ABLE   -ENSTRUAL IRREGU SUSPECTEDCONSULTATIONWITHAHEMATOLOGISTMAY

LARITIESAREASSOCIATEDWITHBOTHHYPOTHYROIDISM BE THE MOST COST EFFECTIVE OPTION IN THE ABSENCE
 PERCENT OF CASES AND HYPERTHYROIDISM OF REASONABLE SCREENING TESTS FOR SPECIFIC ABNOR
 PERCENT OF CASES  ;3TRENGTH OF RECOM MALITIES "ECAUSE JAUNDICE AND HEPATOMEGALY
MENDATION3/2 "#ONSISTENTCOHORTSTUDIES= MAYSUGGESTUNDERLYINGACQUIREDCOAGULOPATHY
4HYROID FUNCTION TESTS MAY HELP THE PHYSICIAN LIVER FUNCTION TESTS SHOULD BE CONSIDERED
DETERMINE THE ETIOLOGY /BESITYACNEHIRSUTISMANDACANTHOSISNIGRI
)NHERITED COAGULOPATHY HAS BEEN SHOWN TO CANS MAY BE SIGNS OF POLYCYSTIC OVARY SYN
BE THE UNDERLYING CAUSE OF ABNORMAL UTERINE DROME OR DIABETES MELLITUS 0OLYCYSTIC OVARY
BLEEDING IN  PERCENT OF WHITE WOMEN AND SYNDROME IS ASSOCIATED WITH UNOPPOSED ESTRO
 PERCENT OF BLACK WOMEN WITH MENORRHAGIA GEN STIMULATION ELEVATED ANDROGEN LEVELS AND
4HESE PATIENTS MAY PRESENT IN ADOLESCENCE WITH INSULIN RESISTANCE AND IS A COMMON CAUSE OF
SEVERE MENSTRUAL BLEEDING OR FREQUENT BRUISING ANOVULATIONP 
! COMPLETE BLOOD COUNT WITH PLATELET COUNT 4HE PRESENCE OF GALACTORRHEA AS DETERMINED
SHOULD BE OBTAINED )F A COAGULATION DEFECT IS BY THE HISTORY OR PHYSICAL EXAMINATION MAY

!02),    6/,5-%  .5-"%2  WWWAAFPORGAFP !-%2)#!. &!-),9 0(93)#)!. 

 USEFUL IN DELINEATING THE UNDERLYING CAUSE OF
$YSFUNCTIONAL UTERINE BLEEDING IS DIAGNOSED BY EXCLUDING ABNORMAL UTERINE BLEEDING THAT IS ASSOCIATED
PREGNANCY IATROGENIC CAUSES SYSTEMIC CONDITIONS AND WITH UTERINE ENLARGEMENT OR AN ADNEXAL MASS
GENITAL TRACT PATHOLOGY %VENIFTHEPELVICEXAMINATIONISNORMALFURTHER
EVALUATIONOFTHEENDOMETRIUMMAYBEREQUIRED
TO ELIMINATE LESS OBVIOUS ABNORMALITIES
$YSFUNCTIONAL UTERINE BLEEDING WITH BOTH
ANOVULATORY AND LESS COMMONLY OVULATORY
INDICATEUNDERLYINGHYPERPROLACTINEMIAWHICH CAUSES OCCURS DURING THE CHILDBEARING YEARS )T
CAN CAUSE OLIGO OVULATION OR EVENTUAL AMENOR ISADIAGNOSISOF EXCLUSIONANDISMADEONLYAFTER
RHEA ! PROLACTIN LEVEL CONFIRMS THE DIAGNOSIS PREGNANCY IATROGENIC CAUSES SYSTEMIC CONDI
OFHYPERPROLACTINEMIA(YPOTHALAMICSUPPRES TIONS AND OBVIOUS GENITAL TRACT PATHOLOGY HAVE
SION SECONDARY TO EATING DISORDERS STRESS OR BEEN RULED OUT &IGURE  
EXCESSIVEEXERCISEMAYINDUCEANOVULATIONWHICH !NOVULATORY DYSFUNCTIONAL UTERINE BLEEDING
SOMETIMESMANIFESTSASIRREGULARANDHEAVYMEN IS A DISTURBANCE OF THE HYPOTHALAMIC PITUITARY
STRUAL BLEEDING OR AMENORRHEA OVARIAN AXIS THAT RESULTS IN IRREGULARPROLONGED
'ENITAL TRACT PATHOLOGY MAY BE ASSOCIATED ANDSOMETIMESHEAVYMENSTRUALBLEEDING)TMAY
WITH INTERMENSTRUAL POSTCOITAL AND HEAVY OCCUR IMMEDIATELY AFTER MENARCHE BUT BEFORE
MENSTRUAL BLEEDING !NY HISTORY OF ABNORMAL MATURATIONOFTHEHYPOTHALAMIC PITUITARY OVAR
0APANICOLAOU 0AP SMEARS SEXUALLY TRANSMIT IAN AXISOR IT MAY OCCUR DURING PERIMENOPAUSE
TED DISEASE GYNECOLOGIC SURGERY TRAUMA OR WHEN DECLINING ESTROGEN LEVELS FAIL TO REGULARLY
SEXUALABUSESHOULDBEELICITED5TERINEFIBROIDS STIMULATE THE ,( SURGE AND RESULTING OVULATION
ENDOMETRIALPOLYPSADENOMYOSISENDOMETRIAL 5NOPPOSED ESTROGEN STIMULATION MAY LEAD
HYPERPLASIAANDATYPIAANDENDOMETRIALCANCER TO ENDOMETRIAL PROLIFERATION AND HYPERPLASIA
SHOULD BE EXCLUDED 7ITHOUT SUFFICIENT PROGESTERONE TO STABILIZE
4HEEVALUATIONOFPOSTMENARCHALWOMENWHO AND DIFFERENTIATE THE ENDOMETRIUMTHIS MUCOUS
PRESENTWITHABNORMALUTERINEBLEEDINGINCLUDES MEMBRANE BECOMES FRAGILE AND SLOUGHS IRREGU
A PELVIC EXAMINATION AS WELL AS A 0AP SMEAR LARLY %STROGEN ALSO AFFECTS UTERINE VASCULAR
IF APPROPRIATE TO LOOK FOR VULVAR OR VAGINAL TONEANGIOGENESISPROSTAGLANDINFORMATIONAND
LESIONS SIGNS OF TRAUMA AND CERVICAL POLYPS ENDOMETRIAL NITRIC OXIDE PRODUCTION
OR DYSPLASIA #ERVICAL DYSPLASIA SELDOM CAUSES /VULATORYDYSFUNCTIONALBLEEDINGMAYINCLUDE
ABNORMALUTERINEBLEEDINGBUTITMAYBEASSOCI POLYMENORRHEAOLIGOMENORRHEAMIDCYCLESPOT
ATED WITH POSTCOITAL BLEEDING #ERVICAL CUL TING AND MENORRHAGIA 4ABLE  PP  0OLY
TURES MAY BE INDICATED IF THE PATIENT IS AT RISK FOR MENORRHEAAPRESUMEDLUTEAL PHASEDYSFUNCTION
INFECTIONORIFSYMPTOMSOFINFECTIONAREPRESENT RESULTS IN SHORTENED CYCLES LESS THAN  DAYS 
! BIMANUAL EXAMINATION IN THE POSTMENARCHAL WHEREAS OLIGOMENORRHEA A PROLONGED FOLLIC
WOMAN MAY REVEAL TENDERNESS ASSOCIATED WITH ULAR PHASE DYSFUNCTION RESULTS IN LENGTHENED
INFECTION AN ADNEXAL MASS CONSISTENT WITH AN CYCLES MORE THAN  DAYS  -IDCYCLE SPOTTING
OVARIAN NEOPLASM OR CYST OR UTERINE ENLARGE OCCURS BEFORE OVULATION AS THE ESTROGEN LEVELS
MENT CONSISTENT WITH FIBROIDS PREGNANCY OR A DECLINE -ENORRHAGIA IS REGULARLY OCCURRING
TUMOR HEAVYMENSTRUALBLEEDINGMORETHANM,PER
"ECAUSEENDOMETRIALABNORMALITIESAREPRES CYCLE AND MAY RESULT FROM THE LOSS OF LOCAL
ENT IN  PERCENT OF PATIENTS WITH A 0AP RESULT ENDOMETRIAL HEMOSTASIS
OF hATYPICAL GLANDULAR CELLS OF UNDETERMINED
SIGNIFICANCEFAVORENDOMETRIALORIGINvENDOME &URTHER %VALUATION "ASED ON 2ISK
TRIALBIOPSYISINDICATED ;3/2"OBSERVATIONAL &ACTORS FOR %NDOMETRIAL #ANCER
STUDIES= 4RANSVAGINAL ULTRASONOGRAPHY MAY BE &URTHER EVALUATION OF ABNORMAL UTERINE

 !-%2)#!. &!-),9 0(93)#)!. WWWAAFPORGAFP 6/,5-%  .5-"%2   !02),  

 !BNORMAL 5TERINE "LEEDING IN 7OMEN OF #HILDBEARING !GE

(ISTORY AND PHYSICAL EXAMINATION

0REGNANCY

9ES .O

$ISCUSS OPTIONS )ATROGENIC CAUSES

MANAGE PREGNANCY

9ES .O

$ISCUSS OPTIONS AND MODIFY 3YSTEMIC CONDITION

MEDICATIONS AND HERBAL
SUPPLEMENTS
9ES .O

-EDICAL MANAGEMENT /BVIOUS GENITAL

TRACT PATHOLOGY

9ES .O

&URTHER TESTING 0RESUMED DYSFUNCTIONAL

AND MANAGEMENT UTERINE BLEEDING

#ERVICAL %NDOCERVICAL POLYPS %NLARGED UTERUS OR 4RAUMATIC INJURY #ERVICITIS OR

DYSPLASIA ADNEXAL MASS ENDOMETRITIS

0OLYPECTOMY !PPROPRIATE TREATMENT

#OLPOSCOPY 5LTRASONOGRAPHY INCLUDING PSYCHOSOCIAL !NTIBIOTIC
ECTOPIC PREGNANCY INTERVENTION THERAPY
LEIOMYOMA OVARIAN OR
ENDOMETRIAL TUMOR

3URGICAL CONSULTATION

&)'52%3EQUENTIALSTEPSTHROUGHTHEDIFFERENTIALDIAGNOSISOFABNORMALUTERINEBLEEDINGINWOMENOF
CHILDBEARING AGE
)NFORMATION FROM REFERENCES  AND 

BLEEDING DEPENDS ON THE PATIENTS AGE AND THE %NDOMETRIAL CANCER IS RARE IN  TO  YEAR
PRESENCE OF RISK FACTORS FOR ENDOMETRIAL CANCER OLD FEMALES 4HEREFOREMOST ADOLESCENTS WITH
WHICHINCLUDEANOVULATORYCYCLESOBESITYNULLI DYSFUNCTIONAL UTERINE BLEEDING CAN BE TREATED
PARITY AGE GREATER THAN  YEARS AND TAMOXIFEN SAFELY WITH HORMONE THERAPY AND OBSERVATION
THERAPY )NITIALLYMEDICALMANAGEMENTISREC WITHOUT DIAGNOSTIC TESTING
OMMENDEDFORPREMENOPAUSALWOMENATLOWRISK 4HE RISK OF DEVELOPING ENDOMETRIAL CANCER
FOR ENDOMETRIAL CARCINOMA WHO ARE DIAGNOSED INCREASES WITH AGE 4HE OVERALL INCIDENCE OF
WITH PRESUMED DYSFUNCTIONAL UTERINE BLEEDING THIS CANCER IS  CASES PER  IN WOMEN
$IABETES IS A DEMONSTRATED RISK FACTOR FOR AGED  TO  YEARS 4HE INCIDENCE MORE THAN
ENDOMETRIAL CANCER 7OMEN WITH LONG OR DOUBLES FROM  CASES PER  IN THOSE
IRREGULAR CYCLES ARE AT RISK FOR DEVELOPING TYPE  AGED  TO  YEARS TO  CASES PER 
DIABETES AND THEREFORE SHOULD UNDERGO DIABETES IN THOSE AGED  TO  YEARS )N WOMEN AGED
SCREENING  TO  YEARS THE INCIDENCE OF ENDOMETRIAL

!02),    6/,5-%  .5-"%2  WWWAAFPORGAFP !-%2)#!. &!-),9 0(93)#)!. 

 4!",% 
4ERMS 5SED TO $ESCRIBE !BNORMAL 5TERINE "LEEDING

4ERM !BNORMAL UTERINE BLEEDING PATTERN

/LIGOMENORRHEA "LEEDING OCCURS AT INTERVALS OF   DAYS AND USUALLY IS CAUSED BY A PROLONGED

FOLLICULAR PHASE
0OLYMENORRHEA "LEEDING OCCURS AT INTERVALS OF   DAYS AND MAY BE CAUSED BY A LUTEAL PHASE
DEFECT
-ENORRHAGIA "LEEDING OCCURS AT NORMAL INTERVALS  TO  DAYS BUT WITH HEAVY FLOW
 * M, OR DURATION  * DAYS 
-ENOMETRORRHAGIA "LEEDING OCCURS AT IRREGULAR NONCYCLIC INTERVALS AND WITH HEAVY FLOW
 * M, OR DURATION  * DAYS 
!MENORRHEA "LEEDING IS ABSENT FOR  MONTHS OR MORE IN A NONMENOPAUSAL WOMAN
-ETRORRHAGIA OR BLEEDING )RREGULAR BLEEDING OCCURS BETWEEN OVULATORY CYCLES CAUSES TO CONSIDER INCLUDE
INTERMENSTRUAL CERVICAL DISEASE INTRAUTERINE DEVICE ENDOMETRITIS POLYPS SUBMUCOUS MYOMAS
ENDOMETRIAL HYPERPLASIA AND CANCER
-IDCYCLE SPOTTING 3POTTING OCCURS JUST BEFORE OVULATION USUALLY BECAUSE OF A DECLINE IN THE
ESTROGEN LEVEL
0OSTMENOPAUSAL BLEEDING "LEEDING RECURS IN A MENOPAUSAL WOMAN AT LEAST  YEAR AFTER CESSATION OF CYCLES
!CUTE EMERGENT ABNORMAL "LEEDING IS CHARACTERIZED BY SIGNIFICANT BLOOD LOSS THAT RESULTS IN HYPOVOLEMIA
UTERINE BLEEDING HYPOTENSION OR TACHYCARDIA OR SHOCK
$YSFUNCTIONAL UTERINE 4HIS OVULATORY OR ANOVULATORY BLEEDING IS DIAGNOSED AFTER THE EXCLUSION OF
BLEEDING PREGNANCY OR PREGNANCY RELATED DISORDERS MEDICATIONS IATROGENIC CAUSES
OBVIOUS GENITAL TRACT PATHOLOGY AND SYSTEMIC CONDITIONS

)NFORMATION FROM REFERENCE 

4HE !UTHORS CARCINOMA IS  CASES PER  4HUS THE
*!.%4 2 !,"%23 -$ IS ASSOCIATE PROFESSOR AND ASSOCIATE CHAIR IN THE $EPARTMENT OF !MERICAN #OLLEGE OF /BSTETRICIANS AND 'YNE
&AMILY AND #OMMUNITY -EDICINE AT 3OUTHERN )LLINOIS 5NIVERSITY 3)5 3CHOOL OF -EDICINE COLOGISTS RECOMMENDS ENDOMETRIAL EVALUATION
3PRINGFIELD WHERE SHE IS ALSO DIRECTOR OF THE FAMILY PRACTICE RESIDENCY PROGRAM $R !LBERS
RECEIVED HER MEDICAL DEGREE FROM 3)5 3CHOOL OF -EDICINE AND COMPLETED A FAMILY PRAC
IN WOMEN AGED  YEARS AND OLDER WHO HAVE
TICE RESIDENCY AT -AYO 'RADUATE 3CHOOL OF -EDICINE 2OCHESTER -INN ABNORMALUTERINEBLEEDING ;3/2#CONSENSUS
3(!2/. + (5,, -$ CURRENTLY IS ON PROFESSIONAL DEVELOPMENT LEAVE FROM 3)5 3CHOOL OF
GUIDELINE=
-EDICINE WHERE SHE IS ASSISTANT PROFESSOR IN THE $EPARTMENT OF &AMILY AND #OMMUNITY %NDOMETRIAL EVALUATION INCLUDING IMAGING
-EDICINE AND CLINICAL ASSISTANT PROFESSOR IN THE $EPARTMENT OF -EDICAL %DUCATION $R (ULL AND TISSUE SAMPLING FOR SUBTLE GENITAL TRACT
EARNED HER MEDICAL DEGREE AT 3)5 3CHOOL OF -EDICINE AND COMPLETED A FAMILY PRACTICE
RESIDENCY AT 5NION (OSPITAL &AMILY 0RACTICE #ENTER 4ERRE (AUTE )ND
PATHOLOGYISRECOMMENDEDINPATIENTSWHOAREAT
HIGH RISK FOR ENDOMETRIAL CANCER AND IN PATIENTS
2/"%24 - 7%3,%9 -! IS DIRECTOR OF RESEARCH AND PROGRAM DEVELOPMENT IN THE
$EPARTMENT OF &AMILY AND #OMMUNITY -EDICINE AT 3)5 3CHOOL OF -EDICINE (E RECEIVED
AT LOW RISK WHO CONTINUE BLEEDING ABNORMALLY
A MASTERS DEGREE IN SOCIOLOGYANTHROPOLOGY FROM 3ANGAMON 3TATE 5NIVERSITY 3PRING DESPITE MEDICAL MANAGEMENT
FIELD )LL

!DDRESS CORRESPONDENCE TO *ANET 2 !LBERS -$ 3OUTHERN )LLINOIS 5NIVERSITY 3CHOOL OF )MAGING AND 4ISSUE 3AMPLING
-EDICINE 3PRINGFIELD &AMILY 0RACTICE 2ESIDENCY 0ROGRAM  . TH 3T 3PRINGFIELD ), 4HE SENSITIVITY OF ENDOMETRIAL BIOPSY FOR THE
 E MAIL JALBERS SIUMEDEDU  2EPRINTS ARE NOT AVAILABLE FROM THE AUTHORS
DETECTIONOFENDOMETRIALABNORMALITIESHASBEEN
REPORTED TO BE AS HIGH AS  PERCENT (OW

 !-%2)#!. &!-),9 0(93)#)!. WWWAAFPORGAFP 6/,5-%  .5-"%2   !02),  

 !BNORMAL 5TERINE "LEEDING

EVERTHIS OFFICE BASED PROCEDURE MAY MISS UP TO CANCER IT NO LONGER IS CONSIDERED TO BE THERA
 PERCENT OF FOCAL LESIONS INCLUDING POLYPS PEUTIC FOR ABNORMAL UTERINE BLEEDING FURTHER
AND FIBROIDS BECAUSE ONLY A SMALL PART OF THE MORE IT IS LIMITED IN ITS ABILITY TO ACCESS THE
ENDOMETRIUM MAY BE SAMPLED AT ANY ONE TIME TUBAL CORNUA OF THE UTERUS (YSTEROSCOPY WITH
!LTHOUGHENDOMETRIALBIOPSYHASHIGHSENSITIVITY BIOPSY PROVIDES MORE INFORMATION THAN DILATA
FORENDOMETRIALCARCINOMA ITSSENSITIVITYFOR TION AND CURETTAGE ALONE AND RIVALS THE COM
DETECTING ATYPICAL ENDOMETRIAL HYPERPLASIA MAY BINATION OF SALINE INFUSION SONOHYSTEROGRAPHY
BE AS LOW AS  PERCENT ;2EFERENCE  3/2 ANDENDOMETRIALBIOPSYINITSABILITYTODIAGNOSE
" META ANALYSIS OF LOWER QUALITYINCONSISTENT POLYPS SUBMUCOUS FIBROIDS AND OTHER SOURCES
STUDIES= OF ABNORMAL UTERINE BLEEDING
4RANSVAGINAL ULTRASONOGRAPHY MAY REVEAL 0OSTMENOPAUSALWOMENWITHABNORMALUTERINE
LEIOMYOMA ENDOMETRIAL THICKENING OR FOCAL BLEEDINGINCLUDINGTHOSEWHOHAVEBEENRECEIV
MASSES!LTHOUGHTHISIMAGINGMODALITYMAYMISS ING HORMONE THERAPY FOR MORE THAN  MONTHS
ENDOMETRIALPOLYPSANDSUBMUCOUSFIBROIDSITIS SHOULD BE OFFERED DILATATION AND CURETTAGE FOR
HIGHLYSENSITIVEFORTHEDETECTIONOF ENDOMETRIAL EVALUATIONOFTHEENDOMETRIUMPERCENTSEN
CANCERPERCENT ANDENDOMETRIALABNORMAL SITIVITY FOR THE DETECTION OF CANCER WITH A  TO 
ITYPERCENT ;3/2!META ANALYSISOF CON PERCENT FALSE NEGATIVE RATE  0OSTMENOPAUSAL
SISTENT GOOD QUALITY STUDIES= #OMPARED WITH WOMEN WHO ARE POOR CANDIDATES FOR GENERAL
DILATATION AND CURETTAGE ENDOMETRIAL EVALUA ANESTHESIAANDTHOSEWHODECLINEDILATATIONAND
TION WITH TRANSVAGINAL ULTRASONOGRAPHY MISSES CURETTAGE MAY BE OFFERED TRANSVAGINAL ULTRASO
 PERCENT MORE CANCERS BUT IT MAY BE THE NOGRAPHYORSALINE INFUSIONSONOHYSTEROGRAPHY
MOST COST EFFECTIVE INITIAL TEST IN WOMEN AT LOW WITH ENDOMETRIAL BIOPSY
RISKFORENDOMETRIALCANCERWHOHAVEABNORMAL &URTHERRESEARCHISNECESSARYTODETERMINETHE
UTERINEBLEEDINGTHATDOESNOTRESPONDTOMEDI BESTMETHODFOREVALUATINGTHEENDOMETRIUMIN
CAL MANAGEMENT PATIENTS WITH ABNORMAL UTERINE BLEEDING(OW
3ALINE INFUSION SONOHYSTEROGRAPHY BOLSTERS EVER BASED ON CURRENT EVIDENCE SALINE INFU
THE DIAGNOSTIC POWER OF TRANSVAGINAL ULTRASO SIONSONOHYSTEROGRAPHYWITHENDOMETRIALBIOPSY
NOGRAPHY 4HIS TECHNIQUE ENTAILS ULTRASOUND APPEARSTOPROVIDETHEMOSTCOMPLETEEVALUATION
VISUALIZATION AFTER  TO  M, OF STERILE SALINE WITH THE LEAST RISK &IGURES  AND  
HAS BEEN INSTILLED IN THE ENDOMETRIAL CAVITY )TS
SENSITIVITYANDSPECIFICITYFORENDOMETRIALCANCER -EDICAL -ANAGEMENT
ARE COMPARABLE WITH THE HIGH SENSITIVITY AND !./65,!4/29 $93&5.#4)/.!,
SPECIFICITY OF DIAGNOSTIC HYSTEROSCOPY ;3/2 54%2).% ",%%$).'
" META ANALYSIS WITH SIGNIFICANT HETEROGENE /RAL CONTRACEPTIVE PILLS /#0S ARE USED FOR
ITY= 3ALINE INFUSION SONOHYSTEROGRAPHY IS MORE CYCLE REGULATION AND CONTRACEPTION )N PATIENTS
ACCURATE THAN TRANSVAGINAL ULTRASONOGRAPHY WITH IRREGULAR CYCLES SECONDARY TO CHRONIC
IN DIAGNOSING INTRACAVITARY LESIONS AND IS ANOVULATION OR OLIGO OVULATION /#0S HELP TO
MORE ACCURATE THAN HYSTEROSCOPY IN DIAGNOSING PREVENT THE RISKS ASSOCIATED WITH PROLONGED
ENDOMETRIALHYPERPLASIA 4HECOMBINATIONOF UNOPPOSED ESTROGEN STIMULATION OF THE ENDO
DIRECTEDENDOMETRIALBIOPSYANDSALINE INFUSION METRIUM/#0SEFFECTIVELYMANAGEANOVULATORY
SONOHYSTEROGRAPHY RESULTS IN A SENSITIVITY OF BLEEDINGINPREMENOPAUSALANDPERIMENOPAUSAL
 TO  PERCENT AND A SPECIFICITY OF  TO  WOMEN4REATMENTWITHCYCLICPROGESTINSFORFIVE
PERCENT FOR THE IDENTIFICATION OF ENDOMETRIAL TODAYSPERMONTHISPREFERREDWHEN/#0USE
ABNORMALITY ;2EFERENCES  AND  3/2 " IS CONTRAINDICATED SUCH AS IN SMOKERS OVER AGE
DIAGNOSTIC COHORT STUDIES=  AND WOMEN AT RISK FOR THROMBOEMBOLISM
!LTHOUGH DILATATION AND CURETTAGE HAS BEEN 4ABLE  
THE GOLD STANDARD FOR DIAGNOSING ENDOMETRIAL

!02),    6/,5-%  .5-"%2  WWWAAFPORGAFP !-%2)#!. &!-),9 0(93)#)!. 

 0RESUMED $YSFUNCTIONAL 5TERINE "LEEDING IN 7OMEN OF #HILDBEARING !GE
%VALUATION "ASED ON 2ISK &ACTORS FOR %NDOMETRIAL #ANCER

0RESUMED DYSFUNCTIONAL UTERINE BLEEDING

2ISK FACTORS FOR ENDOMETRIAL CANCER CHRONIC ANOVULATORY

CYCLES OBESITY NULLIPARITY AGE GREATER THAN  YEARS
DIABETES MELLITUS TAMOXIFEN .OLVADEX THERAPY

.O 9ES

0ATIENT AT LOW RISK FOR 0ATIENT AT HIGH RISK FOR

ENDOMETRIAL CANCER ENDOMETRIAL CANCER

-EDICAL MANAGEMENT %NDOMETRIAL BIOPSY

"LEEDING STOPS "LEEDING CONTINUES !TYPIA (YPERPLASIA .ORMAL

OR CANCER

/BSERVE 4RANSVAGINAL ULTRASONOGRAPHY

#YCLE WITH "LEEDING CONTINUES
'YNECOLOGIC PROGESTINS
REFERRAL
%NDOMETRIAL STRIPE 3ALINE INFUSION
!NOTHER BIOPSY IN SONOHYSTEROGRAPHY
 TO  MONTHS OR DIAGNOSTIC
HYSTEROSCOPY
WITH DIRECTED ENDO
) MM /BVIOUS PATHOLOGY   MM‚ METRIAL BIOPSY

"LEEDING CONTINUES 'YNECOLOGIC REFERRAL 3ALINE INFUSION

SONOHYSTEROGRAPHY
.ORMAL 0ATHOLOGY OR
FOCAL LESION
3ALINE INFUSION
SONOHYSTEROGRAPHY
"LEEDING
OR DIAGNOSTIC 5NIFORM THICKENING OF   MM OF A
.ORMAL &OCAL LESION CONTINUES 'YNECOLOGIC
HYSTEROSCOPY SINGLE LAYER OF THE ENDOMETRIUM
WITH DIRECTED ENDO REFERRAL
OR INCONCLUSIVE RESULTSÂ
METRIAL BIOPSY
"LEEDING 'YNECOLOGIC 'YNECOLOGIC
CONTINUES REFERRAL REFERRAL
%NDOMETRIAL BIOPSY

.ORMAL 0ATHOLOGY OR
'YNECOLOGIC
FOCAL LESION
REFERRAL
!TYPIA OR (YPERPLASIA .ORMAL
"LEEDING CANCER
CONTINUES 'YNECOLOGIC
REFERRAL #YCLE WITH "LEEDING
PROGESTINS CONTINUES
'YNECOLOGIC
'YNECOLOGIC REFERRAL
REFERRAL
!NOTHER BIOPSY 'YNECOLOGIC
IN  TO  MONTHS REFERRAL

ˆ4RANSVAGINAL ULTRASONOGRAPHY IDEALLY IS PERFORMED DURING THE LATE PROLIFERATIVE PHASE

‚ˆ3OME INVESTIGATORS CONSIDER AN ENDOMETRIAL STRIPE OF  TO  MM OR LARGER TO BE ABNORMAL IN PREMENOPAUSAL OR PERIMENOPAUSAL WOMEN
ˆ4HESE DETERMINANTS ARE BASED ON INFORMATION FROM REFERENCE 

&)'52%%VALUATIONOFWOMENOFCHILDBEARINGAGEWITHPRESUMEDDYSFUNCTIONALUTERINEBLEEDINGBASEDONRISKFORENDOMETRIALCAN
CER
 !BNORMAL 5TERINE "LEEDING

!BNORMAL 5TERINE "LEEDING IN 0OSTMENOPAUSAL 7OMEN

0OSTMENOPAUSAL ABNORMAL UTERINE BLEEDING

(ORMONE THERAPY .O HORMONE THERAPY OR HORMONE THERAPY

FOR  MONTHS FOR   MONTHS WITH BLEEDING

/BSERVE BLEEDING FOR  YEAR /FFER DILATATION AND CURETTAGE

BEFORE DIAGNOSING
ABNORMAL UTERINE BLEEDING

.ORMAL 0ATHOLOGY

!DJUST HORMONE 'YNECOLOGIC REFERRAL

THERAPY IF INDICATED

"LEEDING CONTINUES

3ALINE INFUSION SONOHYSTEROGRAPHY OR HYSTEROS

COPY WITH DIRECTED ENDOMETRIAL BIOPSY

.ORMAL 0ATHOLOGY OR FOCAL LESION

!DJUST HORMONE THERAPY 'YNECOLOGIC REFERRAL

IF INDICATED

"LEEDING CONTINUES

'YNECOLOGIC REFERRAL

ˆ0OSTMENOPAUSAL WOMEN WHO ARE POOR CANDIDATES FOR GENERAL ANESTHESIA OR WHO DECLINE DILATATION AND CURET
TAGE MAY BE OFFERED TRANSVAGINAL ULTRASONOGRAPHY OR SALINE INFUSION SONOHYSTEROGRAPHY WITH ENDOMETRIAL BIOPSY

&)'52%  %VALUATION OF ABNORMAL UTERINE BLEEDING IN POSTMENOPAUSAL WOMEN

/65,!4/29 $93&5.#4)/.!, 54%2).% ",%%$).' MEFENAMIC ACID 0ONSTEL  AN .3!)$ FOR THE
TREATMENT FOR MENORRHAGIA THIS AGENT IS WELL
-EDICAL THERAPY FOR MENORRHAGIA PRIMARILY TOLERATED ;3/2 ! META ANALYSIS= 4HE LEVO
INCLUDESNONSTEROIDALANTI INFLAMMATORYDRUGS NORGESTRELCONTRACEPTIVEDEVICEHASBEENSHOWN
.3!)$S AND THE LEVONORGESTREL RELEASING TO DECREASE MENSTRUAL BLOOD LOSS SIGNIFICANTLY
INTRAUTERINESYSTEM-IRENA 4HE53&OODAND AND TO BE SUPERIOR TO CYCLIC PROGESTINS FOR THIS
$RUG !DMINISTRATION HAS APPROVED THE USE OF PURPOSE ;3/2 ! META ANALYSIS=

!02),    6/,5-%  .5-"%2  WWWAAFPORGAFP !-%2)#!. &!-),9 0(93)#)!. 

 4!",% 
-EDICAL -ANAGEMENT OF !NOVULATORY $YSFUNCTIONAL 5TERINE "LEEDING

!GENT $OSAGE 0URPOSE OF TREATMENT

#OMBINATION /#0
 TO  MCG OF ETHINYL ESTRADIOL PLUS A #YCLE REGULATION
PROGESTIN MONOPHASIC OR TRIPHASIC PILL TAKEN #ONTRACEPTION
DAILY TRANSDERMAL FORMS ALSO ARE AVAILABLE 0REVENTION OF ENDOMETRIAL
HYPERPLASIA
 MCG PILL FROM TWICE DAILY TO EVERY SIX HOURS -ANAGEMENT OF
FOR FIVE TO SEVEN DAYS UNTIL MENSES IS STOPPED NONEMERGENCY HEAVY
FOLLOWED BY TAPER TO ONE PILL DAILY FOR BLEEDING
COMPLETION OF  DAY PACK THEN ONE /#0
PACKET PER MONTH FOR THREE TO SIX MONTHS
#ONJUGATED ESTROGENS  MG )6 EVERY  TO  HOURS UNTIL BLEEDING -ANAGEMENT OF ACUTE
)6 0REMARIN CEASES OR FOR  HOURS THEN /#0 AS ABOVE EMERGENCY BLEEDING
0ROGESTINS
-EDROXYPROGESTERONE  OR  MG PER DAY FOR  TO  DAYS PER MONTH #YCLE REGULATION
ACETATE 0ROVERA
.ORETHINDRONE  TO  MG PER DAY FOR  TO  DAYS PER 0REVENTION OF ENDOMETRIAL
ACETATE !YGESTIN MONTH HYPERPLASIA
-ICRONIZED PROGESTERONE  MG PER DAY FOR  DAYS PER MONTH
0ROMETRIUM

/#0  ORAL CONTRACEPTIVE PILL )6  INTRAVENOUS

ˆ/#0S SHOULD NOT BE USED IN SMOKERS  YEARS AND OLDER OR IN WOMEN AT RISK FOR THROMBOEMBOLISM
!DAPTED WITH PERMISSION FROM !PGAR "3 'REENBERG ' 5SING PROGESTINS IN CLINICAL PRACTICE !M &AM 0HYSICIAN
   WITH ADDITIONAL INFORMATION FROM REFERENCES  AND 

4!",%  !LTHOUGH THE EFFECT OF /#0S ON MENORRHAGIA

3URGICAL -ANAGEMENT OF !BNORMAL 5TERINE "LEEDING HASNOTBEENWELLSTUDIEDONESMALLRANDOMIZED
TRIALCOMPARING/#0SMEFENAMICACIDNAPROXEN
3URGICAL PROCEDURE 2EASON FOR SURGERY AND DANAZOL SHOWED NO SIGNIFICANT DIFFERENCE
IN THEIR EFFECTIVENESS IN TREATING MENORRHAGIA
/PERATIVE HYSTEROSCOPY )NTRACAVITARY STRUCTURAL ABNORMALITIES
-YOMECTOMY ABDOMINAL ,EIOMYOMA
;3/2 " SINGLE RANDOMIZED CONTROLLED TRIAL=
LAPAROSCOPIC HYSTEROSCOPIC 3IDE EFFECTS AND COST LIMIT THE USE OF ANDROGENS
4RANSCERVICAL ENDOMETRIAL 4REATMENT RESISTANT MENORRHAGIA OR SUCH AS DANAZOL AND GONADOTROPIN RELEASING
RESECTION MENOMETRORRHAGIA HORMONE AGONISTS IN THE TREATMENT OF MENOR
%NDOMETRIAL ABLATION USING 4REATMENT RESISTANT MENORRHAGIA OR RHAGIA BUT THESE AGENTS MAY BE USED FOR SHORT
VARIOUS ENERGY SYSTEMS MENOMETRORRHAGIA SECONDARILY FOR TERM ENDOMETRIAL THINNING BEFORE ABLATION IS
PRINCIPALLY THERMAL BALLOON OR MANAGEMENT OF TREATMENT RESISTANT ACUTE
ROLLERBALL UTERINE HEMORRHAGE
PERFORMED ;3/2 ! META ANALYSIS=
5TERINE ARTERY EMBOLIZATION ,EIOMYOMA !NTIFIBRINOLYTICS SIGNIFICANTLY REDUCE HEAVY
(YSTERECTOMY !TYPICAL HYPERPLASIA ENDOMETRIAL CANCER MENSTRUAL BLEEDING (OWEVER THESE AGENTS ARE
OR BLEEDING THAT DOES NOT RESPOND TO LESS USED INFREQUENTLY BECAUSE OF CONCERNS ABOUT
INVASIVE UTERUS SPARING SURGERIES SAFETY IE POTENTIAL FOR THROMBOEMBOLISM 
)NTRAVENOUS ADMINISTRATION OF CONJUGATED
ESTROGENS0REMARIN MAYBEREQUIREDINWOMEN

 !-%2)#!. &!-),9 0(93)#)!. WWWAAFPORGAFP 6/,5-%  .5-"%2   !02),  

 !BNORMAL 5TERINE "LEEDING

WITHACUTEUTERINEHEMORRHAGE ;3/2"SINGLE

RANDOMIZED CONTROLLED STUDY=  &ERENCZY ! 'ELFAND -- (YPERPLASIA VERSUS
NEOPLASIA TWO TRACKS FOR THE ENDOMETRIUM #ON
TEMP /"'9.  
3URGICAL -ANAGEMENT  2OSENTHAL !. 0ANOSKALTSIS 4 3MITH 4 3OUTTER 70
7HEN MEDICAL THERAPY FAILS OR IS CONTRA 4HE FREQUENCY OF SIGNIFICANT PATHOLOGY IN WOMEN
ATTENDING A GENERAL GYNAECOLOGICAL SERVICE FOR POST
INDICATEDSURGICALINTERVENTIONMAYBEREQUIRED COITAL BLEEDING "*/'  
(YSTERECTOMY IS THE TREATMENT OF CHOICE WHEN  #HHIENG $# %LGERT 0 #OHEN *- #ANGIARELLA *&
ADENOCARCINOMA IS DIAGNOSED AND THIS PROCE #LINICAL IMPLICATIONS OF ATYPICAL GLANDULAR CELLS OF
UNDETERMINED SIGNIFICANCE FAVOR ENDOMETRIAL ORI
DURE ALSO SHOULD BE CONSIDERED WHEN BIOPSY
GIN #ANCER  
SPECIMENS CONTAIN ATYPIA (YSTERECTOMY AND  !PGAR "3 $YSMENORRHEA AND DYSFUNCTIONAL UTERINE
VARIOUS UTERUS SPARING SURGICAL PROCEDURES FOR BLEEDING 0RIM #ARE  
THE TREATMENT OF ABNORMAL UTERINE BLEEDING ARE  "RINTON ,! "ERMAN -, -ORTEL 2 4WIGGS ," "ARRETT
2* 7ILBANKS '$ ET AL 2EPRODUCTIVE MENSTRUAL AND
BEYOND THE SCOPE OF THIS ARTICLE BUT ARE LISTED IN MEDICAL RISK FACTORS FOR ENDOMETRIAL CANCER RESULTS
4ABLE  FROM A CASE CONTROL STUDY !M * /BSTET 'YNECOL
 
4HE AUTHORS INDICATE THAT THEY DO NOT HAVE ANY CON  2IES ,! %ISNER -0 +OSARY #, (ANKEY "& -ILLER "!
FLICTS OF INTEREST 3OURCES OF FUNDING NONE REPORTED #LEGG , ET AL EDS 3%%2 CANCER STATISTICS REVIEW
 "ETHESDA-D.ATIONAL#ANCER)NSTITUTE
!CCESSED-ARCHATHTTPSEERCANCER
2%&%2%.#%3
GOVCSR?
 .ICHOLSON 7+ %LLISON 3! 'RASON ( 0OWE .2 0AT  3OLOMON#'(U&"$UNAIF!2ICH %DWARDS*7ILLETT
TERNS OF AMBULATORY CARE USE FOR GYNECOLOGIC CON 7# (UNTER $* ET AL ,ONG OR HIGHLY IRREGULAR MEN
DITIONS A NATIONAL STUDY !M * /BSTET 'YNECOL STRUAL CYCLES AS A MARKER FOR RISK OF TYPE  DIABETES
  MELLITUS *!-!  
 'OODMAN ! !BNORMAL GENITAL TRACT BLEEDING #LIN  %LFORD +* 3PENCE *% 4HE FORGOTTEN FEMALE PEDIATRIC
#ORNERSTONE   AND ADOLESCENT GYNECOLOGICAL CONCERNS AND THEIR
 (ILL .# /PPENHEIMER ,7 -ORTON +% 4HE AETIOLOGY REPRODUCTIVE CONSEQUENCES * 0EDIATR !DOLESC 'YNE
OF VAGINAL BLEEDING IN CHILDREN !  YEAR REVIEW "R COL  
* /BSTET 'YNAECOL    !#/' PRACTICE BULLETIN -ANAGEMENT OF ANOVULA
 ,IVINGSTONE - &RASER )3 -ECHANISMS OF ABNOR TORY BLEEDING )NT * 'YNAECOL /BSTET  
MAL UTERINE BLEEDING (UM 2EPROD 5PDATE  
   3TOVALL 4' ,ING &7 -ORGAN 0, ! PROSPECTIVE
 ,ETHABY ! &ARQUHAR # 3ARKIS ! 2OBERTS ( *EP RANDOMIZED COMPARISON OF THE 0IPELLE ENDOME
SON 2 "ARLOW $ (ORMONE REPLACEMENT THERAPY IN TRIAL SAMPLING DEVICE WITH THE .OVAK CURETTE !M *
POSTMENOPAUSAL WOMEN ENDOMETRIAL HYPERPLASIA /BSTET 'YNECOL  PT   
AND IRREGULAR BLEEDING #OCHRANE $ATABASE 3YST 2EV  'OLDSTEIN 32 :ELTSER ) (ORAN #+ 3NYDER *2 3CHWARTZ
 #$ ," 5LTRASONOGRAPHY BASED TRIAGE FOR PERIMENO
 3PEROFF , 'LASS 2( +ASE .' #LINICAL GYNECOLOGIC PAUSAL PATIENTS WITH ABNORMAL UTERINE BLEEDING !M
ENDOCRINOLOGY AND INFERTILITY TH ED "ALTIMORE ,IP * /BSTET 'YNECOL  
PINCOTT 7ILLIAMS  7ILKINS     #LARK 4* -ANN #( 3HAH . +HAN +3 3ONG & 'UPTA
 3HWAYDER *- 0ATHOPHYSIOLOGY OF ABNORMAL UTER *+ !CCURACY OF OUTPATIENT ENDOMETRIAL BIOPSY IN THE
INE BLEEDING /BSTET 'YNECOL #LIN .ORTH !M  DIAGNOSIS OF ENDOMETRIAL CANCER A SYSTEMATIC QUANTI
  TATIVE REVIEW "*/'  
 /RIEL +! 3CHRAGER 3 !BNORMAL UTERINE BLEEDING !M  $IJKHUIZEN &0 -OL "7 "ROLMANN (! (EINTZ !0 4HE
&AM 0HYSICIAN   ACCURACY OF ENDOMETRIAL SAMPLING IN THE DIAGNOSIS OF
 !#/' PRACTICE BULLETIN #LINICAL MANAGEMENT GUIDE PATIENTS WITH ENDOMETRIAL CARCINOMA AND HYPERPLA
LINES FOR OBSTETRICIAN GYNECOLOGISTS 5SE OF BOTANI SIA A META ANALYSIS #ANCER  
CALS FOR MANAGEMENT OF MENOPAUSAL SYMPTOMS  4ABOR ! 7ATT (# 7ALD .* %NDOMETRIAL THICKNESS
/BSTET 'YNECOL  SUPPL   AS A TEST FOR ENDOMETRIAL CANCER IN WOMEN WITH
 +RASSAS '% 4HYROID DISEASE AND FEMALE REPRODUC POSTMENOPAUSAL VAGINAL BLEEDING /BSTET 'YNECOL
TION &ERTIL 3TERIL    
 $ILLEY ! $REWS # -ILLER # ,ALLY # !USTIN ( 2AMAS  3MITH "INDMAN2+ERLIKOWSKE+&ELDSTEIN6!3UBAK
WAMY $ ET AL 6ON 7ILLEBRAND DISEASE AND OTHER , 3CHEIDLER * 3EGAL - ET AL %NDOVAGINAL ULTRASOUND
INHERITED BLEEDING DISORDERS IN WOMEN WITH DIAG TO EXCLUDE ENDOMETRIAL CANCER AND OTHER ENDOME
NOSEDMENORRHAGIA/BSTET'YNECOL  TRIAL ABNORMALITIES *!-!   
 &RANKS 3 0OLYCYSTIC OVARY SYNDROME ;PUBLISHED COR  -EDVERD *2 $UBINSKY 4* #OST ANALYSIS MODEL 53
RECTION APPEARS IN . %NGL * -ED = VERSUS ENDOMETRIAL BIOPSY IN EVALUATION OF PERI AND
. %NGL * -ED   POSTMENOPAUSAL ABNORMAL VAGINAL BLEEDING 2ADI

!02),    6/,5-%  .5-"%2  WWWAAFPORGAFP !-%2)#!. &!-),9 0(93)#)!. 

!BNORMAL 5TERINE "LEEDING

OLOGY 
  !PGAR "3 'REENBERG ' 5SING PROGESTINS IN CLINICAL
 #LARK 4* 6OIT $ 'UPTA *+ (YDE # 3ONG & +HAN PRACTICE!M&AM0HYSICIAN


+3 !CCURACY OF HYSTEROSCOPY IN THE DIAGNOSIS OF 
ENDOMETRIAL CANCER AND HYPERPLASIA A SYSTEMATIC  $E6ORE '2 /WENS / +ASE . 5SE OF INTRAVENOUS
QUANTITATIVE REVIEW *!-! 
 0REMARIN IN THE TREATMENT OF DYSFUNCTIONAL UTER

 $E 6RIES ,$ $IJKHUIZEN &0 -OL "7 "ROLMANN (! INE BLEEDINGˆA DOUBLE
BLIND RANDOMIZED CONTROL
-ORET % (EINTZ !0 #OMPARISON OF TRANSVAGINAL STUDY /BSTET 'YNECOL 

SONOGRAPHY SALINE INFUSION SONOGRAPHY AND HYS
 ,ETHABY ! !UGOOD # $UCKITT + .ONSTEROIDAL ANTI

TEROSCOPY IN PREMENOPAUSAL WOMEN WITH ABNORMAL INFLAMMATORY DRUGS FOR HEAVY MENSTRUAL BLEEDING
UTERINE BLEEDING * #LIN 5LTRASOUND  
 #OCHRANE $ATABASE 3YST 2EV  #$
 +RAMPL % "OURNE 4 (URLEN
3OLBAKKEN ( )STRE /  ,ETHABY !% #OOKE ) 2EES - 0ROGESTERONE PRO

4RANSVAGINAL ULTRASONOGRAPHY SONOHYSTEROGRAPHY
AND OPERATIVE HYSTEROSCOPY FOR THE EVALUATION OF
ABNORMAL UTERINE BLEEDING !CTA /BSTET 'YNECOL
3CAND 
  #$
GESTOGEN RELEASING INTRAUTERINE SYSTEMS VERSUS
EITHER PLACEBO OR ANY OTHER MEDICATION FOR HEAVY
MENSTRUAL BLEEDING #OCHRANE $ATABASE 3YST 2EV
 7IDRICH 4 "RADLEY ,$ -ITCHINSON !2 #OLLINS 2,  &RASER )3 -C#ARRON ' 2ANDOMIZED TRIAL OF  HOR

#OMPARISON OF SALINE INFUSION SONOGRAPHY WITH MONAL AND  PROSTAGLANDIN
INHIBITING AGENTS IN
OFFICE HYSTEROSCOPY FOR THE EVALUATION OF THE ENDO
WOMEN WITH A COMPLAINT OF MENORRHAGIA !UST . : *
METRIUM !M * /BSTET 'YNECOL  
 /BSTET 'YNAECOL 

 /#ONNELL ,0 &RIES -( :ERINGUE % "REHM 7 4RIAGE OF  3OWTER -# ,ETHABY ! 3INGLA !! 0RE
OPERATIVE
ABNORMAL POSTMENOPAUSAL BLEEDING A COMPARISON ENDOMETRIAL THINNING AGENTS BEFORE ENDOMETRIAL
OF ENDOMETRIAL BIOPSY AND TRANSVAGINAL SONOHYS
DESTRUCTION FOR HEAVY MENSTRUAL BLEEDING #OCHRANE
TEROGRAPHY VERSUS FRACTIONAL CURETTAGE WITH HYSTEROS
$ATABASE 3YST 2EV  #$
COPY !M * /BSTET 'YNECOL 
  ,ETHABY ! &ARQUHAR # #OOKE ) !NTIFIBRINOLYTICS FOR
 -IHM ,- 1UICK 6! "RUMFIELD *! #ONNORS !& *R HEAVY MENSTRUAL BLEEDING #OCHRANE $ATABASE 3YST
&INNERTY ** 4HE ACCURACY OF ENDOMETRIAL BIOPSY 2EV  #$
AND SALINE SONOHYSTEROGRAPHY IN THE DETERMINATION
OF THE CAUSE OF ABNORMAL UTERINE BLEEDING !M *
/BSTET 'YNECOL 

 "EN
9EHUDA /- +IM 9" ,EUCHTER 23 $OES HYSTEROS

COPY IMPROVE UPON THE SENSITIVITY OF DILATATION AND
CURETTAGE IN THE DIAGNOSIS OF ENDOMETRIAL HYPERPLASIA
OR CARCINOMA 'YNECOL /NCOL  

 "ETTOCCHI 3 #ECI / 6ICINO - -ARELLO & )MPEDOVO ,
3ELVAGGI , $IAGNOSTIC INADEQUACY OF DILATATION AND
CURETTAGE &ERTIL 3TERIL 

 'IMPELSON 2* 0ANORAMIC HYSTEROSCOPY WITH DIRECTED
BIOPSIES VS DILATATION AND CURETTAGE FOR ACCURATE
DIAGNOSIS * 2EPROD -ED 

 &LEISCHER !# 7HEELER ,% ,INDSAY ) (ENDRIX 3) 'RA

BILL 3 +RAVITZ " ET AL !N ASSESSMENT OF THE VALUE OF
ULTRASONOGRAPHIC SCREENING FOR ENDOMETRIAL DISEASE
IN POSTMENOPAUSAL WOMEN WITHOUT SYMPTOMS !M
* /BSTET 'YNECOL 


 !-%2)#!. &!-),9 0(93)#)!. WWWAAFPORGAFP 6/,5-%  .5-"%2   !02),